3rd Quarter - Report

VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2013, GAO Study regarding National Stockpile to determine storage, distribution, and delivery porcedures of temperature sensitive medicines and vaccines.

LobbyistCovered position, as disclosed
JAMES M CRUM —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: S. 3295 (112th)

Consumer Issues/Safety/Products CSP

Time-Temperature Indicators for Vaccines and Pharmaceuticals technology. H.R.1483, Drug Safety Enhancement Act of 2011, Cold chain temperature related issues. Cold Chain Initiative related issues. H.R.5651, Food & Drug Administration Reform Act, Cold chain temperature related issues.

LobbyistCovered position, as disclosed
JAMES M CRUM —

Contacted: HOUSE OF REPRESENTATIVES

Bills named: H.R. 1483 (112th), H.R. 5651 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.